AF
AZN icon

Alerus Financial’s AstraZeneca AZN Stock Holding History

Alerus Financial’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$111K Buy
+586
New +$110K ﹤0.01% 266
2026
Q1 		– Sell
-909
Closed -$167K – 514
2025
Q4 		$167K Sell
909
-13
-1% -$2.28K 0.01% 176
2025
Q3 		$141K Buy
922
+616
+201% +$93.2K 0.01% 197
2025
Q2 		$42.8K Buy
+306
New +$42.9K ﹤0.01% 259

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Alerus Financial's AZN Position: Q2 2026 in Review

Alerus Financial opened a new position in AstraZeneca (AZN) in Q2 2026: 586 shares worth $111K. The stake represents ﹤0.01% of the portfolio and ranks #266 among its holdings. This is a return to the name: Alerus Financial previously reported a position in AZN as recently as Q4 2025.

Alerus Financial first reported a position in AZN in Q2 2025 and has held it in 4 quarters since. The position peaked at $167K in Q4 2025. 1,503 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Alerus Financial held 586 shares of AstraZeneca worth $111K as of Q2 2026.
  • AstraZeneca was a new Alerus Financial position in Q2 2026.
  • AstraZeneca made up ﹤0.01% of Alerus Financial's portfolio in Q2 2026, its #266 holding.
  • Alerus Financial first reported a position in AstraZeneca in Q2 2025 and has held it in 4 quarters since.
  • Alerus Financial's AstraZeneca position peaked at $167K in Q4 2025.
  • 1,503 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Alerus Financial's 13F filing for Q2 2026, filed 14 Aug 2026.